["{\n\"step_by_step_thinking\": \"The question is about why capsular polysaccharides are conjugated to protein carriers like tetanus toxoid during vaccine development. The key point is that the antibody response to capsular polysaccharide vaccines in young children is often poor or absent, which makes them less effective against Hib infections. Conjugation with a protein carrier improves the immune response by providing a carrier for the B cells to recognize and respond to the antigen.\",\n\"answer_choice\": \"C\""]